= 0.46) and 18j (r 2 = 0.81) against P. falciparum. e Previously reported data. 1 f All compounds were inactive against HepG2 cell lines except for 4b (TC50 = 4.9 µM), 4j (12.9 µM), 4k (9.6 µM), and 18b (10.0 µM). g Not determined due to low solubility in the assay conditions. LCTPremier time-of-flight mass spectrometer (electrospray ionization). GCMS analysis was performed using an Agilent gas chromatograph with a transmission quadrupole mass spectrometer (electron impact). All newly synthesized compounds were deemed >95% pure by LCMS analysis.
S12

S14
ADME Data Tables
Quinazoline compounds 2 and 4b-m were synthesized according to previous published methods. 1 Compounds not characterized and disclosed in that reference are listed below.
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-phenylquinazolin-4-amine (4b, NEU-706).
(Yield: 59%). 
6-(4-(tert-butoxymethyl)phenyl)-N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)quinazolin-4-amine (4f, NEU-635). (Yield: 33%
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)quinazolin-4-amine (4m, NEU-1010).
In minutes. The reaction mixture was concentrated under reduced pressure and purified by column chromatography (hexanes/ethyl acetate) to obtain the product in a 26% yield. 4 In a sealed tube, morpholine (1.990 mL, 23.00 mmol) and 2,5-dibromo-3-methylpyridine (0.398 g, 1.586 mmol) were heated in the microwave at 210 o C for 10 minutes. The reaction mixture was diluted with water and the organic layer was extracted three times with ethyl acetate. The combined organic layers were concentrated under reduced pressure and the product was separated by column chromotagraphy (hexanes/ethyl acetate) to obtain the product in 97% yield. 
6-bromo-N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)thieno[3,2-d]pyrimidin-4-amine (10).
4-(5-bromo-3-methylpyridin-2-yl)morpholine.
N-(tert-butyl)-2-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)thieno[3,2-d]pyrimidin-
6-yl)benzenesulfonamide (11c, NEU-773).
(Yield: 18%). Methyl 2-aminothiophene-3-carboxylate (13). 5 To a stirred solution of methyl 2-cyanoacetate (8.80 mL, 100 mmol) and 1,4-dithiane-2,5-diol (7.61 g, 50.0 mmol) in 40 mL of DMF was added triethylamine (6.97 mL, 50.0 mmol) dropwise over a period of 10 minutes at 25 °C. The reaction mixture was stirred at 45°C for 2 hours and then cooled to room temperature. The mixture was diluted with 0.4 M acetic acid until the pH was 7, and the organic layer was extracted with diethyl ether (100 mL x 3). The combined organic phases were dried over anhydrous sodium sulfate, and evaporation of solvent afforded the product in 58% yield. 
Thieno[2,3-d]pyrimidin-4(3H)-one (14).
A solution of methyl 2-aminothiophene-3-carboxylate (6.7 g, 42.6 mmol) and formamide (34.0 mL, 852 mmol) was stirred at 170°C for 6 hours. The reaction mixture was cooled to room temperature and 100 mL of water was added. It was allowed to stand overnight and then filtered, washed thoroughly with water, and air dried to afford the product in a 38 % yield. 
6-bromo-N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)thieno[2,3-d]pyrimidin-4-amine (17)
. 6 To a solution of 6-bromo-4-chlorothieno [2,3- 
